CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

In its first earnings report since the departure of longtime CEO Joe Kiani, Masimo said Tuesday it is focused on reducing ...

Integra Lifesciences appointed former 3M executive Mojdeh Poul as CEO. Poul will take over from Jan De Witte in January, ...

Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ...

Baxter will share an update on Hurricane Helene’s impact, while Medtronic will likely discuss a new pulsed field ablation ...

Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...

The document clarifies that EtO falls within the scope of the Medical Device Regulation and the In Vitro Diagnostic ...

Patient advocates are hoping for change under new director Michelle Tarver, while industry groups look to build on former ...

The filing follows Exactech’s failure to settle product liability claims from about 2,600 patients in response to recalls of ...

Analysts said the findings complicate the outlook for a U.S. launch of Boston Scientific's aortic valve replacement device.

The three medtech firms unveiled new data this week during TCT 2024 in Washington, D.C. Here’s what the results mean for the ...

However, the company said it will delay a submission for its next-generation Zio cardiac monitoring system until remediation ...